News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
297,585 Results
Type
Article (15395)
Company Profile (298)
Press Release (281885)
Multimedia
Podcasts (96)
Webinars (12)
Section
Business (81584)
Career Advice (171)
Deals (13860)
Drug Delivery (46)
Drug Development (52477)
Employer Resources (31)
FDA (6420)
Job Trends (5562)
News (149855)
Policy (10612)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (961)
Accelerated approval (29)
Adcomms (14)
Allergies (107)
Alliances (22103)
ALS (162)
Alzheimer's disease (1173)
Antibody-drug conjugate (ADC) (397)
Approvals (6777)
Artificial intelligence (360)
Autoimmune disease (240)
Automation (10)
Bankruptcy (106)
Best Places to Work (4962)
BIOSECURE Act (6)
Biosimilars (128)
Biotechnology (228)
Bladder cancer (141)
Brain cancer (58)
Breast cancer (486)
Cancer (4170)
Cardiovascular disease (321)
Career advice (159)
Career pathing (10)
CAR-T (269)
CDC (7)
Celiac Disease (1)
Cell therapy (718)
Cervical cancer (24)
Clinical research (46537)
Collaboration (1452)
Company closure (3)
Compensation (754)
Complete response letters (56)
COVID-19 (1149)
CRISPR (105)
C-suite (757)
Cystic fibrosis (121)
Data (5969)
Denatured (20)
Depression (114)
Dermatology (68)
Diabetes (326)
Diagnostics (1573)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (258)
Drug pricing (53)
Drug shortages (3)
Duchenne muscular dystrophy (270)
Earnings (33787)
Editorial (33)
Employer branding (4)
Employer resources (29)
Events (54666)
Executive appointments (697)
FDA (8752)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (17)
Frontotemporal dementia (32)
Funding (1190)
Gene editing (223)
Generative AI (30)
Gene therapy (607)
GLP-1 (572)
Government (1247)
Grass and pollen (3)
Guidances (183)
Healthcare (6962)
HIV (37)
Huntington's disease (50)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (88)
Immunology and inflammation (236)
Immuno-oncology (78)
Indications (149)
Infectious disease (1311)
Inflammatory bowel disease (186)
Inflation Reduction Act (10)
Influenza (60)
Intellectual property (201)
Interviews (19)
IPO (7691)
IRA (14)
Job creations (892)
Job search strategy (135)
JPM (42)
Kidney cancer (10)
Labor market (29)
Layoffs (253)
Leadership (13)
Legal (1454)
Liver cancer (51)
Longevity (24)
Lung cancer (561)
Lymphoma (315)
Machine learning (35)
Management (7)
Manufacturing (518)
MASH (157)
Medical device (2963)
Medtech (2986)
Mergers & acquisitions (6906)
Metabolic disorders (915)
mRNA (159)
Multiple sclerosis (127)
NASH (14)
Neurodegenerative disease (324)
Neuropsychiatric disorders (83)
Neuroscience (2336)
Neurotech (1)
NextGen: Class of 2026 (2108)
Non-profit (988)
Now hiring (39)
Obesity (407)
Opinion (140)
Ovarian cancer (189)
Pain (144)
Pancreatic cancer (233)
Parkinson's disease (295)
Partnered (13)
Patents (387)
Patient recruitment (497)
Peanut (47)
People (27489)
Pharmaceutical (42)
Pharmacy benefit managers (7)
Phase 1 (16063)
Phase 2 (21305)
Phase 3 (14180)
Pipeline (6046)
Policy (104)
Postmarket research (1004)
Preclinical (6801)
Press Release (35)
Prostate cancer (207)
Psychedelics (58)
Radiopharmaceuticals (275)
Rare diseases (861)
Real estate (1485)
Recruiting (12)
Regulatory (11126)
Reports (20)
Research institute (1014)
Resumes & cover letters (23)
Rett syndrome (35)
RNA editing (27)
RSV (29)
Schizophrenia (153)
Series A (231)
Series B (160)
Service/supplier (1)
Sickle cell disease (90)
Special edition (20)
Spinal muscular atrophy (127)
Sponsored (20)
Startups (2031)
State (1)
Stomach cancer (6)
Supply chain (39)
Tariffs (20)
The Weekly (74)
Vaccines (415)
Venture capital (85)
Weight loss (219)
Women's health (48)
Worklife (2)
Date
Today (23)
Last 7 days (343)
Last 30 days (2003)
Last 365 days (18619)
2026 (7938)
2025 (18885)
2024 (21209)
2023 (23125)
2022 (27581)
2021 (28755)
2020 (24239)
2019 (16929)
2018 (12353)
2017 (14272)
2016 (12302)
2015 (14843)
2014 (10723)
2013 (7730)
2012 (7764)
2011 (7880)
2010 (7634)
Location
Africa (159)
Alabama (73)
Alaska (2)
Arizona (84)
Arkansas (6)
Asia (19008)
Australia (3251)
California (8550)
Canada (2236)
China (991)
Colorado (311)
Connecticut (333)
Delaware (326)
Europe (41593)
Florida (1095)
Georgia (261)
Hawaii (3)
Idaho (17)
Illinois (511)
India (48)
Indiana (235)
Iowa (8)
Japan (349)
Kansas (84)
Kentucky (12)
Louisiana (15)
Maine (13)
Maryland (878)
Massachusetts (6772)
Michigan (128)
Minnesota (310)
Mississippi (3)
Missouri (47)
Montana (17)
Nebraska (6)
Nevada (57)
New Hampshire (22)
New Jersey (2413)
New Mexico (13)
New York (2146)
North Carolina (1039)
North Dakota (7)
Northern California (4332)
Ohio (219)
Oklahoma (11)
Oregon (23)
Pennsylvania (1593)
Puerto Rico (11)
Rhode Island (27)
South America (227)
South Carolina (12)
Southern California (3415)
Tennessee (53)
Texas (1178)
United States (28934)
Utah (122)
Virginia (174)
Washington D.C. (39)
Washington State (707)
West Virginia (1)
Wisconsin (62)
297,585 Results for "c3j therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
May 5, 2026
·
6 min read
Press Releases
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
May 17, 2026
·
10 min read
Press Releases
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
·
4 min read
Press Releases
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026
·
15 min read
Press Releases
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
April 15, 2026
·
10 min read
Press Releases
Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates
May 13, 2026
·
13 min read
Press Releases
Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - May 22, 2026
May 25, 2026
·
3 min read
Press Releases
Halia Therapeutics Appoints Gary Sabin as Executive Chairman and Adds Three Independent Directors to Board
May 19, 2026
·
5 min read
Press Releases
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
May 7, 2026
·
10 min read
Press Releases
Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
April 15, 2026
·
13 min read
1 of 29,759
Next
